Scripts for telehealth: how it fits a virtual clinic

Telehealth ordering is defined by volume, geography, and the need to scale without adding pharmacy management headcount. A virtual clinic places many repeat refills and ships to patients across state lines, which means the ordering platform must route each order to a pharmacy licensed for the patient's state and keep status flowing back without clinical staff making phone calls. Scripts addresses this with multiple partner pharmacies for redundancy, one login and one invoice across the network, and a concierge team handling fulfillment coordination as the clinic's proxy.

Co-founder Jeff Sakamoto has described Scripts as the 'quiet infrastructure' that lets clinics of any size scale safely — a growth partner, not just an ordering tool. For telehealth, the specific proof points to request are the list of partner pharmacies with state licensure coverage that matches your patient population, the API or EHR integration your telemedicine stack requires, and references from comparable telehealth brands.

Fizy Health targets the same telehealth workflow with a different platform model. Pass-through per-vial 503A cost appears on each catalog and cart line before checkout, so a telehealth owner can price a patient program on real numbers without entering a portal first. One clinic cart batches the whole refill day across multiple 503A partners, with cart validation catching invalid SIGs, prescriber state mismatches, and stock gaps before payment — which matters most when a single batch covers patients in many states.

Multi-pharmacy routing then splits one checkout to the right LegitScript-certified 503A partner per line automatically, with per-line tracking and patient notification texts. Support tickets stay in the app tied to the order and patient, so a distant-patient issue keeps its context instead of scattering across email threads. The tradeoff: Fizy Health is currently 503A patient-specific, and does not offer the 503B office-use bulk access that Scripts includes.